It has been clearly demonstrated that ageing and arterial hypertension are both associated with an increased prevalence of left ventricular hypertrophy (LVH), which is a powerful risk factor for cardiovascular (CV) events. The objective of this study was to assess the impact of echocardiographic LVH in profiling the absolute CV risk stratification according to the 1999 World Health Organization-International Society of Hypertension (WHO/ ISH) guidelines in elderly hypertensive patients. A total of 223 never-treated elderly patients (X65 years) with essential hypertension (98 men, 125 women, mean age 72 7 5 years) referred to our outpatient hospital clinic were included in the study. They underwent the following procedures: (1) medical history, physical examination, and clinic blood pressure; (2) routine blood chemistry and urine analysis and (3) electrocardiogram. The risk was initially stratified according to the routine procedures suggested by WHO/ISH guidelines and subsequently reassessed by adding the results of echocardiography (LVH as left ventricular mass index 451 g/m 2.7 in men and 447g/m 2.7 in women). According to routine classification, 56% (n ¼ 125) were medium-risk patients, 29% (64) high-risk and 15% (34) very-high-risk patients. The overall prevalence of LVH was 56% (48% in medium-risk and 62% in high-risk or very-high-risk patients, Po0.01). A marked change in risk stratification was observed when echocardiographic LVH was taken into consideration: medium-risk patients decreased to 29% and high-risk patients rose to 56% (Po0.01).
Introduction
A large body of evidence indicates that antihypertensive treatment confers a protective benefit against stroke, coronary artery disease and heart failure in hypertensive individuals over a wide range of blood pressure (BP) values. 1, 2 Traditionally, BP levels alone were used to initiate antihypertensive drug treatment in patients with hypertension. However, cardiovascular risk is only partially determined by BP and this simple approach appears inadequate for treatment decision-making in patients with grade 1 or 2 hypertension. 3, 4 This fact is fully recognised in both Joint National Committee (JNC) VI and 1999 World Health Organization/International Society of Hypertension (WHO/ISH) guidelines, which presented a risk stratification system based not only on individual average BP level, but also on the presence of other risk factors, target organ damage (TOD) and clinical evidence of cardiovascular or renal disease. 5, 6 While precise information about variables such as the BP levels, coexistent risk factors and associated diseases can be obtained by a complete clinical evaluation integrated by routine investigations, the detection of TOD is dependent on the accuracy of the diagnostic approaches used for this search. Left ventricular hypertrophy (LVH), for example, a powerful independent predictor of cardiovascular events in the general population as well as in hypertensive patients, 7, 8 is routinely screened by electrocardiography, which has limited sensitivity and thus tends to underestimate the real prevalence of this marker of TOD. 9, 10 Although it has been clearly proven that echocardiography is a much more sensitive and specific method for detecting LVH than electrocardiography and X-ray (both indicated as routine examinations by WHO/ ISH guidelines), the systematic use of this technique in order to assess more precisely the level of cardiovascular risk in hypertensive patients is not recommended by guidelines. The aim of the present study was to assess the impact of detection of LVH by echocardiography in modifying the level of absolute cardiovascular risk as estimated by routine examinations according to the 1999 WHO/ISH guidelines in a large group of untreated elderly hypertensive patients, in whom ageing associated with high BP level may induce a high prevalence of cardiac and vascular involvement.
12,13

Methods
Patients and design
The study was performed in elderly patients (X65 years) with recently diagnosed hypertension (o1 year) consecutively attending the outpatient clinic of our hypertension centre during a period of 9 months between 1 April and 31 December 2001. Patients were included if (1) they had never been treated or were untreated during at least the 3 preceding months, (2) their BP values were between 140-179 mmHg (systolic) and/or 90-109 mmHg (diastolic) at two consecutive visits, and (3) they had a good-quality cardiac ultrasonographic examination. Patients with secondary hypertension, congestive heart failure, previous myocardial infarction, history of coronary artery bypass, cardiac valve diseases, stroke, marked reduction in renal function (serum creatinine concentration 4177 mmol/l), and major noncardiovascular diseases were excluded. Those who met the inclusion criteria and gave informed consent to participate were subjected to the following procedures within 1-3 weeks from the initial visit: (1) clinic BP measurement, (2) blood and urine sampling for routine blood chemistry and urine examination, (3) standard 12-lead electrocardiogram, (4) echocardiogram. The study protocol was approved by the ethics committee of the Ospedale Maggiore Policlinico.
BP measurement
BP was measured in the morning (between 0900 and 1200 h) in the outpatient clinic by a physician with a mercury sphygmomanometer (first and fifth phases of Koroktoff sounds taken as SBP and DBP, respectively) after the subjects had rested for 5-10 min in the sitting position. Three measurements were taken at 1 min intervals, and the average was used to define clinic systolic and diastolic BP.
Echocardiography
M-mode, two-dimensional and Doppler echocardiographic examinations were performed with subjects in the partial left decubitus position using a commercially available instrument (ATL HDI 3000, Bothell, WA, USA) equipped with a 2.25 MHz imaging transducer. End-diastolic and end-systolic left ventricular internal diameter (LVIDd, LVIDs) and interventricular septum thickness (IVST) and posterior wall thickness (PWT) were calculated from two-dimensionally guided Mmode tracings and measured during five consecutive cardiac cycles according to the Penn Convention.
14 Left ventricular (LV) mass was estimated by Devereux's formula 15 and indexed to height 2.7 . 16 LV systolic function was assessed by the calculation of fractional endocardial shortening (LVIDdÀLVIDs)/ LVIDd. As reported previously, the intraobserver and interobserver coefficients of variations for LV mass index in our laboratory are 7.4 and 8.7%, respectively. 17 
Stratification by absolute level of cardiovascular risk
We defined the level of global cardiovascular risk of each patient according to the criteria suggested by the 1999 WHO/ISH guidelines. The risk stratification was thus based on BP, age, smoking, serum cholesterol, family history of premature cardiovascular disease, diabetes and the presence of TOD and clinical cardiovascular or renal disease. Detection of the usual cardiovascular risk factors and diagnosis of cardiovascular or renal disease were accomplished by careful medical history and physical examination and by the routine laboratory investigations recommended by the guidelines. TOD was identified if the above routine examinations indicated the presence of proteinuria, a slight elevation of plasma creatinine concentration (106-177 mmol/l) or electrocardiographic signs of LVH. To detect LVH, we used two different electrocardiographic criteria: the Sokolow-Lyon voltage (sum of amplitude of S wave in V1 and R wave in V5 or V6X35 mm) and the gender-specific Cornell criteria (sum of amplitude of S wave in V3 and R wave in aVL 420 mm in women and 428 in men). 18, 19 Cardiovascular risk was then requantified based on the echocardiographic data. LVH was diagnosed when LVMI exceeded 51 g/m 2.7 in men and 47 g/m 2.7 in women. 20 Patterns of left ventricular geometry were defined according to Ganau et al: 21 (1) LV concentric remodelling when a normal LVMI was combined with a relative wall thickness (RWT ¼ 2PWT/LVIDd)X0.45; (2) concentric LVH when LVH occurred with an RWTX0.45; (3) eccentric LVH when increased LV mass was associated with an RWT o0.45. 
Statistical analysis
Results
Study population
Recruitment of patients began in April 2001 and ended in December of the same year. The screening process, performed during the first visit at our outpatient unit, involved 253 untreated elderly grade I or II hypertensive subjects potentially eligible for the study (see exclusion criteria). Of these, 23 were not included for echocardiographic reasons: insufficient/poor quality of M-mode LV tracings (15 patients), significant mitral and/or aortic regurgitation (10 patients), valvular aortic stenosis (two patients) and asymmetric hypertrophic cardiomyopathy (one patient). Five other patients were excluded because of too low BP values (o140/90 mmHg) at the second visit or because of their unwillingness to participate.
Of the 223 patients who were included in the study, 98 were men and 125 women. The mean age was 72 7 5 years. The mean clinical BP was 159 7 11/94 7 7 mmHg. Their demographic and clinical characteristic are shown in Table 1 .
Prevalence of TOD on the basis of routine procedures
In all, 10 patients (4.6%) had electrocardiographic signs of LVH (four according to Sokolow-Lyon criteria and six according to Cornell criteria). Of the patients, 61 (27.7%) showed renal involvement as suggested by proteinuria and/or slight increase of plasma creatinine concentration. Overall, with this routine clinical approach, cardiac and/or renal TOD was diagnosed in 66 patients (29.5%).
Echocardiographic data
Of the 223 patients, 124 were found to have LVH, as defined by sex-specific echocardiographic criteria of 51 g/m 2.7 in men and 47 g/m 2.7 in women, with an overall prevalence of 56%. LVH was eccentric in 31.5% of patients and concentric in 24.1%. A further 15.3% of patients exhibited LV concentric remodelling and consequently only 29.2% of our population showed a normal LV geometry. The degree of LVH was generally mild and LVMI ranged from 52 to 98 g/m 2.7 in men and from 48 to 91 g/m 2.7 in women. Of the patients with electrocardiographic signs of LVH, eight out of 10 had the diagnosis confirmed by echocardiographic criteria.
Impact on cardiovascular risk stratification of echocardiographic LVH
The distribution of patients in the different categories of absolute cardiovascular disease risk on the basis of clinical work-up was as follows: 125 patients were classified in the medium-risk stratum (56%), 64 patients in the high-risk stratum (29%) and 34 in the very-high-risk stratum (15%) ( Table 2 ). The prevalence of LVH according to sex-specific criteria of 51/47 g/m 2.7 was 48% in medium-risk patients and 62% in high-risk or very-high-risk patients (Po0.01). A significant change in the risk strata distribution was observed when echocardiographic detection of LVH was included in the algorithm: 29% were in the medium-risk stratum, while as many as 56% were classified in the highrisk stratum (Po0.01), and 15% remained in the very-high-risk stratum (Figure 1 ).
Discussion
The finding of the present survey that global risk stratification in elderly hypertensive patients is dependent on the sensitivity and accuracy of the diagnostic work-up used in the detection of TOD, and namely in the detection of LVH, could be considered, so to say, an expected result. However, important outcomes of this study are (1) the quantification of the risk reclassification obtained by echocardiographic procedures, and (2) the indication of the hypertensive patients in whom ultrasound assessment of cardiac TOD is more likely to change risk stratification. Our data show that nearly 50% of the untreated elderly hypertensive patients seen in a hospital hypertension clinic, who were initially classified in the medium-risk stratum of the WHO/ISH guidelines as a result of a routine diagnostic work-up, changed their risk category after adding cardiac examination. This evidence underlines that the routine diagnostic work-up for hypertension is a highly insensitive approach to the identification of patients having TOD and that routine echocardiography should be recommended to avoid systematic underestimation of cardiovascular risk in a large number of elderly hypertensives. As to the types of hypertensive patients in whom risk stratification can be improved by cardiac ultrasound, our study, carried out in grades I and II hypertensives, demonstrates that an increased sensitivity of TOD detection does not reclassify risk in patients already stratified in the high (as well as very-high)-risk class. Both JNC VI and WHO/ISH guidelines, although recognizing the usefulness of echocardiography in assessing TOD, are rather vague in their recommendations, and suggest its use when there is clinical suspicion of LVH or of other cardiac diseases. In addition, the JNC VI underlines that echocardiography might usefully be performed in patients assigned a low-risk score because of the absence of associated cardiovascular risk factors and TOD, and for this reason not entitled to a pharmacological treatment. In this context, our findings offer a new piece of information, suggesting that echocardiography might be particularly useful in elderly patients that routine investigations classify at medium risk, as a considerable fraction of these patients may be reclassified at higher risk by ultrasonography; as a consequence, they should be subjected to a prompter and more intensive pharmacological treatment, as recommended by the guidelines. The requirement for echocardiography in patients already classified as being at high risk, by routine examination, for whom prompt and intensive treatment is in any case recommended, appears not to be indicated for treatment decision-making. 22 Some other aspects of our study deserve to be discussed. First, our findings confirm the results of four previous studies investigating the impact of ultrasound cardiac and vascular examinations in selected hypertensive patients over a wide range of age, also showing that clinical evaluation based on simple routine work-up underestimates the overall cardiovascular risk in a significant proportion of them. [23] [24] [25] [26] [27] In a recent study by our group performed in 100 low-or medium-risk hypertensives (mean age 44 years), a percentage of patients, ranging from 9 to 25%, were found to have LVH according to different criteria, and consequently moved from low-and medium-risk strata to the high-risk stratum. 25 The Assessment of Prognostic Risk Observational Survey (APROS) study showed that 36.9% of 1074 hypertensive subjects seen in 44 hospital hypertension clinics, who were initially classified in the lower risk strata, according to WHO/ISH guidelines, ).
Echocardiography in elderly hypertensives
C Cuspidi et al changed their risk category to the higher one because of the echographic demonstration of LVH. 26 Our analysis extends those findings to a large sample of never-treated elderly hypertensives, by highlighting the pivotal role of echocardiography to risk classification in this important subset of hypertensive population. Our study demonstrates that a larger proportion of subjects (48%) not requiring immediate treatment by the WHO/ISH guidelines would be reclassified at a higher CV risk after echocardiographic detection of LVH, suggesting that the impact of this diagnostic approach is more profitable in elderly than in younger hypertensives. 25 This evidence may be reasonably explained considering that both population-and selected hypertensive sample-based studies demonstrated that aging is an important factor associated with an increase in LV wall thickness, LV mass and prevalence of LVH. 28, 29 Second, we have already underlined that this study was conducted on a relatively selected group of patients referred to a specialistic centre, and therefore the per cent shift toward a higher risk when echocardiographic data are added refers to the patients attending the hypertension hospital clinic only. Third, the prevalence of LVH is dependent on the echocardiographic criteria used for the diagnosis. 29, 30 We have used a sex-specific partition value of 51 g/m 2.7 in men and 47 g/m 2.7 in women in order to detect mild forms of LVH also in overweight and obese patients, because the application of particularly conservative diagnostic criteria for defining LVH, instead of less restrictive ones, can systematically underestimate the overall risk in a significant proportion of patients. In fact, a linear, independent and powerful relation exists between LV mass and cardiovascular risk in initially untreated essential hypertensives, 31 and LVH is independently associated with risk for cardiovascular complications regardless of the use of genderspecific or gender-independent indexes adjusted for body surface area or height. 32 Finally, a brief comment with regard to the fact that in our evaluation of TOD retinal alterations such as narrowings or initial arterio-venous crossings (grade I or I-II) were not considered among the criteria for risk classification. A particularly high prevalence of these retinal abnormalities at nonmydriatic retinography was recently found in a large sample of grade I and II hypertensives by our group. 24 If considered a proof of TOD, these alterations would have classified almost all subjects in the high-risk class.
In conclusion, our study shows that (1) the use of echocardiography allows a much more accurate identification of high-risk individuals with preclinical TOD in a substantial proportion of untreated elderly patients (significantly higher than that found in previous studies mostly performed in middleaged hypertensives), (2) the full benefit of risk reclassification by echocardiography can be obtained by concentrating this procedure in patients initially defined at medium risk in routine evaluation, and (3) traditional cardiovascular stratification, based on minimum work-up recommended by the guidelines, might often markedly underestimate the effective global risk, leading to potential inadequate management of this growing group of the hypertensive population.
